Searched for
CIPLA EARNINGS REPORT
Zaynich's blockbuster potential lifts Wockhardt's long-term outlookWockhardt's novel antibiotic, Zaynich, has received USFDA approval after a 12-year effort, sparking hopes for a turnaround after years of n...02 Jun, 2026, 05.48 AM IST- Q4 earnings review: Motilal Oswal highlights broad-based beat on estimates, lists 6 sectors that exceeded expectationsMotilal Oswal said Q4 FY26 earnings surpassed expectations, with aggregate profits rising 16% year-on-year against its 8% estimate. Strong ...01 Jun, 2026, 01.12 PM IST
- Geopolitical stability will decide market’s next move: Sandip SabharwalIndian equity markets are holding above 24,000, buoyed by improving sentiment and steady earnings, though geopolitical tensions remain a co...26 May, 2026, 12.11 PM IST
- Mankind, other pharma stocks rally up to 7%; Nifty Pharma scales fresh peak. What lies ahead?Pharma stocks surged on Wednesday, supported by strong earnings and a weakening rupee, even as Sensex and Nifty traded lower. The Nifty Pha...20 May, 2026, 12.05 PM IST
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%Here’s a thing investors in equity need to keep in mind. A large part of the upmove one might see in the next one or two trading sessions w...18 May, 2026, 10.31 PM IST
- NLC India shares rally 18% to fresh record high after Q4 net profit skyrockets 189% YoYNLC India shares rose to a record high on Thursday after the company posted a 189% YoY surge in Q4 net profit to Rs 1,394 crore. Revenue ro...14 May, 2026, 12.05 PM IST
- Iran war halts but missiles would echo in Q4 results: 40 stocks may report over 20% profit dipIndia's corporate earnings for the quarter ended March 2026 are feeling the economic heat from the recent Israel-US-Iran conflict. While so...09 Apr, 2026, 11.37 AM IST
- Tariff threat ain't over yet! Sun Pharma, other pharma stocks plunge up to 6%Pharma stocks fell after reports that the Trump administration may impose tariffs—potentially up to 100%—on drugmakers not ensuring low pri...02 Apr, 2026, 12.13 PM IST
- Cipla reports Rs 1049 crore net profit in Q3FY24, on strong US, India salesDrug maker Cipla reported a 33% year-on-year (YoY) jump in net profit to Rs 1049 crore in Q3FY24, led by strong US and India sales momentum.23 Jan, 2024, 02.06 PM IST
- Cipla gains 3% on USFDA nod to market Lanreotide"This approval is a significant step for our US business and is in line with our aspiration to continue growth in our complex product pipel...20 Dec, 2021, 10.50 AM IST
- Analysts expect Cipla to return up to 30% from here on as India biz gains momentumKotak Securities said the expansion of the Covid portfolio would support near-term earnings while the continued rollout of respiratory fran...18 May, 2021, 07.23 AM IST
- Neutral on Cipla, target price Rs 840: Motilal OswalCipla Ltd., incorporated in the year 1935, is a Large Cap company (having a market cap of Rs 72908.31 Crore) operating in Pharmaceuticals s...17 May, 2021, 10.08 AM IST
- Brokerages raise targets on CiplaCipla’s shares hit a record high of Rs 814.45 on Monday before ending at Rs 795.65, up 9.2 per cent from the previous close. Cipla reported...11 Aug, 2020, 07.33 AM IST
- Buy Cipla, target price Rs 523: Nirmal BangTthe brokerage has downward revised its FY21 and FY22 forecasts on Cipla, having knocked off Voltaren sales number and pushed Albuterol inh...31 Mar, 2020, 12.44 PM IST
- Brokerages slash Cipla’s target price on weak Q4 earningsCipla reported a consolidated net loss of Rs 61.8 crore for the quarter ended March.27 May, 2017, 10.37 AM IST
- Cipla posts 44% rise in Q2 net profit; India sales flatIn the past quarter, Cipla posted Rs 3,452 crore of revenue, compared with Rs 2,767 crore a year earlier.06 Nov, 2015, 01.44 AM IST
- Nomura lowers Cipla’s rating on high valuation, earnings concernsNomura has set a price target of Rs 569 for the stock, implying 9% potential downside from the Thursday’s closing price of Rs 622.19 Sep, 2014, 07.20 AM IST
Load More
